
Tylenol, Theraflu, NyQuil, and DayQuil
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Juneau et al. v. The Procter & Gamble Co. and GSK Consumer Healthcare, Inc.
23-cv-5273, E.D. La.
(Sept. 2023)
DayQuil Severe, NyQuil Severe Cold & Flu, Theraflu Multi-Symptom Severe Cold/Severe Cold Cough, and other cold and flu medicines
Falsely marketing that medicines treat nasal congestion when the active ingredient (phenylephrine) is not an effective decongestant
Pending
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Falsely marketing that medicines are decongestants
Allegations: Falsely marketing the products treat nasal congestion
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Allegations: Falsely marketing that medicines treat nasal congestion
Allegations: Misleadingly marketing drink mixes using the phrase “Natural fruit flavor” and images of raspberries when they contain artificial flavoring ingredients
Allegations: Misleadingly marketing products as if they treat symptoms of coughs and colds
Allegations: False natural claims
Allegations: False natural claims
When did the soap game get so dirty?
Green marketing claims you should think twice about.
Self-regulatory body calls supporting evidence behind superiority claims “materially flawed.”
What’s in a name? Sometimes not what you expect.
Here’s what the Super Bowl’s #likeagirl ad really means.